Drug Shortage Report for MANNITOL INJECTION USP
Report ID | 155784 |
Drug Identification Number | 00038016 |
Brand name | MANNITOL INJECTION USP |
Common or Proper name | Mannitol Injection USP |
Company Name | ICU MEDICAL CANADA INC |
Market Status | MARKETED |
Active Ingredient(s) | MANNITOL |
Strength(s) | 20% |
Dosage form(s) | SOLUTION |
Route of administration | INTRAVENOUS INTRAVENOUS |
Packaging size | 500 mL |
ATC code | B05BC |
ATC description | I.V. SOLUTIONS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | 2022-04-04 |
Actual start date | |
Estimated end date | 2022-05-30 |
Actual end date | 2022-05-30 |
Shortage status | Resolved |
Updated date | 2022-05-31 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 2600 BOUL ALFRED-NOBEL, SUITE 100 SAINT LAURENT, QUEBEC CANADA H4S 0A9 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v1 | 2022-03-01 | English | Compare |
v2 | 2022-03-01 | French | Compare |
v3 | 2022-03-29 | English | Compare |
v4 | 2022-04-01 | English | Compare |
v5 | 2022-04-01 | French | Compare |
v6 | 2022-04-05 | English | Compare |
v7 | 2022-05-09 | English | Compare |
v8 | 2022-05-09 | French | Compare |
v9 | 2022-05-12 | English | Compare |
v10 | 2022-05-12 | French | Compare |
v11 | 2022-05-31 | English | Compare |
v12 | 2022-05-31 | French | Compare |
Showing 1 to 12 of 12